Sleep Apnea

Sleep Apnea: A Nutrition and Natural-Health Reference

1. Definition and Characterization

Sleep apnea (SA) is a respiratory disorder characterized by intermittent reductions (hypopnea) or full cessation (apnea) of breathing for a few seconds or as long as a few minutes; these episodes may occur many times during sleep. More than one billion individuals worldwide currently experience some form of sleep apnea, and the number of individuals carrying this diagnosis has been rising steadily.

Several types of this disorder have been identified, but the two most prominent forms are obstructive and central sleep apnea. Obstructive sleep apnea (OSA), which is the more common of the two forms, is believed to result from complete or partial obstruction of the upper airway during sleep. By contrast, central sleep apnea (CSA) results from dysfunction of the respiratory control centers of the brain stem, most notably the pre-Bötzinger complex; in CSA, the respiratory control center fails to provide the signal to inhale, causing the individual to miss one or more breathing cycles while asleep.

Severity Classification

OSA is diagnosed through sleep studies, including polysomnography (PSG), which monitors airflow, blood oxygen levels, brain waves, and body movements during sleep. The apnea-hypopnea index (AHI) measures the frequency of apnea and hypopnea events per hour of sleep and is commonly used to determine severity. The AHI categorizes the disorder as mild, moderate, or severe, with severe cases presenting with more than 30 events per hour.

2. Body Systems Involved

Upper Airway and Musculoskeletal System

OSA is a sleep disorder whereby breathing repeatedly stops due to obstruction and collapse of the pharynx within the upper airway. The pathophysiology underlying OSA is attributable to both anatomical (structural) and neuromuscular (nonstructural) elements. As a part of both the respiratory and digestive systems, the pharynx connects the mouth and nasal cavity above to the esophagus and larynx below. The pharynx is made up of soft tissue and over 20 muscles, allowing it to be both flexible and collapsible.

Important pathophysiological components likely include upper airway anatomy, the ability of the upper airway dilator muscles to respond to respiratory challenge during sleep, the propensity to wake from increased respiratory drive during sleep (arousal threshold), the stability of the respiratory control system (loop gain), and the potential for state-related changes in lung volume to influence these factors.

Central Nervous System

Sleep is a complex physiological mechanism that involves the actions of numerous components of the central nervous system (CNS). Critical roles are played by the ascending reticular activating system (ARAS) that controls vegetative functions, and electroencephalographic findings are associated with both sleep apnea and normal sleep. MTN neurons respond to hypothalamic GABA release by releasing glutamate that activates neurons in the ARAS, and a dysfunctional MTN may be incapable of activating neurons in the ARAS, notably those in the parabrachial nucleus, ultimately leading to sleep apnea.

Cardiovascular and Autonomic Systems

These frequent interruptions in breathing not only impact the quality of sleep but also place a substantial burden on the cardiovascular, metabolic, and neurological systems. The ventilatory inadequacies and their accompanying intermittent hypoxemia often lead to transient arousals from sleep and sleep state fragmentation throughout the night, and cause overcompensatory responses of the autonomic nervous system.

Chronic intermittent hypoxia (CIH), the main attribute of OSA, produces oxidative stress, endothelial dysfunction, and hypertension. OSA is associated with a significant increase in cardiovascular morbidity and mortality due to intermittent hypoxia-induced sympathetic activation.

Metabolic System

Intermittent hypoxia (IH), one of the primary pathologies of sleep apnea syndrome, exposes cells throughout the body to repeated cycles of hypoxia/normoxia that result in oxidative stress and systemic inflammation. Sleep apnea is epidemiologically strongly correlated with type 2 diabetes/insulin resistance, obesity, hypertension, and dyslipidemia included in metabolic syndrome. Intermittent hypoxia, sleep fragmentation, elevated sympathetic tone, and oxidative stress — all consequences of OSA — have been implicated in the progression of poor metabolic outcomes.

Oxidative Stress Pathways

Intermittent hypoxia increases oxygen free radicals (ROS) and reduces antioxidant capacities. Oxidative stress and metabolic alterations lead OSA patients to undergo endothelial dysfunction, osteoporosis, systemic inflammation, increased cardiovascular risk, pulmonary remodeling, and neurological alterations.

3. Contributing and Associated Factors

Obesity and Body Composition

Increases in body mass index, central accumulation of adipose tissue, and neck circumference are strong predictors of disease. Obesity predisposes to OSA, and the prevalence of OSA is increasing worldwide because of the ongoing epidemic of obesity. Recent evidence has shown that surrogate markers of cardiovascular risk, including sympathetic activation, systemic inflammation, and endothelial dysfunction, are significantly increased in obese patients with OSA versus those without OSA, suggesting that OSA is not simply an epiphenomenon of obesity.

There is consistent evidence that weight gain was associated with incident and greater severity of OSA. In patients with the metabolic syndrome, the prevalence of moderate to severe OSA is very high (approximately 60%).

Age, Sex, and Genetics

The prevalence of OSA is two to three times greater in men than in women and in older individuals (≥65 years) compared with middle-aged individuals (30–64 years). One study observed an association of a specific genetic polymorphism in rs12415421, as well as insulin resistance/hyperglycemia, with incident OSA.

Comorbid Medical Conditions

In a review of 34 studies conducted in 28 countries with a sample of 37,599 people, several comorbidities were identified in patients with severe OSA — these were: heart disease, stroke, kidney disease, asthma, COPD, acute heart failure, chronic heart failure, hyperlipidemia, thyroid disease, cerebral infarct or embolism, myocardial infarction, and psychological comorbidities including stress and depression.

Type 2 diabetes, insulin resistance, and glucose intolerance are common in subjects with OSA, and this association is at least in part independent of the effects of obesity.

Smoking

Smoking causes airway muscle inflammation. The inflammation of muscle leads to narrowing of the airways. Smoking and alcohol worsened sleep apnea symptoms across analyzed studies.

Alcohol

Alcohol is a modifiable risk factor that can result in the development or worsening of OSA. Alcohol causes excessive relaxation of throat muscles during sleep, making it easier for the pharynx to collapse and trigger more obstructive events. As a result, individuals with OSA experience an increase in the frequency and duration of apneas/hypopneas after consuming alcoholic beverages, as well as a more pronounced drop in oxygen saturation.

A systematic review and meta-analysis of randomized controlled trials examined the impact of alcohol on breathing parameters during sleep. The meta-analysis of 14 eligible studies (n = 422; 71.9% male) found that AHI increased significantly after alcohol administration. Consumption of alcohol resulted in significant worsening of the AHI and mean oxygen saturation in sleep. This was especially notable in subjects with a history of OSA and snoring. Alcohol also appeared to result in prolongation of respiratory event duration.

Nasal Congestion and Anatomical Factors

Chronic nasal congestion can obstruct airflow during sleep; nasal polyps and chronic sinusitis lead to breathing difficulties during sleep.

Environmental Factors

Long-term exposure to ambient air pollution (NO₂) was associated with OSA, and menopausal transitions with higher apnea-hypopnea index in longitudinal research.

4. Nutrients Studied in Relation to Sleep Apnea

Vitamin D

Scientific Evidence: A comprehensive review published in the Journal of Sleep Research explored the emerging connection between vitamin D deficiency and OSA, discussing potential mechanisms. Recent research has consistently highlighted the high incidence of vitamin D deficiency among patients with OSA, which often occurs independently of geographical location — suggesting that factors beyond lack of sunlight exposure may be involved.

Potential mechanisms proposed include the role of vitamin D deficiency in promoting inflammation, oxidative stress, hypoxia, impairing immune function, muscle function, and gene polymorphism of vitamin D receptors, all of which could contribute to the pathogenesis of obstructive sleep apnea.

There has been a surge in interest regarding the connection between sleep duration and quality, sleep disorders, mainly OSA, and vitamin D. A notable link has been identified between OSA and a decrease in serum vitamin D levels, which appears to intensify as the severity of sleep apnea worsens. Some studies have found improvements in sleep quality and a reduction in OSA severity following vitamin D supplementation.

Vitamin D receptors (VDR) have been identified in nearly all tissues in the body, including both neuronal and glial cells in the central nervous system. VDR are present in multiple areas of the human brain, including the prefrontal cortex, cingulate gyrus, thalamus, substantia nigra, hippocampus, and also the hypothalamus, a brain area that regulates the sleep-wake cycle among other behaviors.

The current body of evidence underscores the need for future research to validate these observations, to determine optimal vitamin D supplementation dosage and duration, to explore potential side effects and risks, and to investigate potential interactions with other treatments. Evidence to date is therefore characterized as observational and preliminary, with causal relationships yet to be firmly established in large randomized trials.

Magnesium

Scientific Evidence: Low levels of magnesium are frequently observed in individuals diagnosed with obstructive sleep apnea compared to healthy individuals. This deficiency can potentially exacerbate symptoms by contributing to muscle relaxation issues, including those affecting the pharyngeal muscles that keep the airway open. Adequate magnesium levels also support the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that promotes relaxation and deep, restful sleep.

Evidence linking magnesium supplementation specifically to reduced OSA severity is largely indirect and observational. Magnesium's role in GABA neurotransmission and muscle tone has mechanistic plausibility, but dedicated clinical trials targeting OSA as a primary endpoint remain limited.

Omega-3 Fatty Acids (EPA and DHA)

Scientific Evidence: Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are powerful anti-inflammatory compounds. These fatty acids can help reduce the production of inflammatory molecules that drive the chronic inflammation seen in OSA patients. Since inflammation contributes to tissue stress and potential swelling in the airway, the anti-inflammatory effects of omega-3s may help reduce the severity of sleep apnea symptoms.

The current evidence for omega-3 supplementation in OSA is primarily mechanistic and indirect, grounded in omega-3's well-documented anti-inflammatory properties and OSA's known inflammatory pathology. Direct interventional trials specifically targeting AHI reduction via omega-3 supplementation are limited and small.

N-Acetylcysteine (NAC)

Scientific Evidence: NAC is an antioxidant that reduces intermittent hypoxia resulting from excitation of the sympathetic nervous system. In an animal model of sleep apnea, supplementation with NAC mitigated oxidative stress and inflammation that occurred as a result of intermittent hypoxia. In a randomized placebo-controlled trial in 20 adults with obstructive sleep apnea, 600 mg NAC given three times daily for 30 days resulted in significant reductions in AHI, apnea-related arousals, oxygen desaturation, daytime sleepiness, and snoring.

OSA is associated with a significant increase in cardiovascular morbidity and mortality due to intermittent hypoxia-induced sympathetic activation. Animal studies have elucidated the causal role of free radicals and reactive oxygen species (ROS) in this phenomenon. Research demonstrates that N-AC decreases muscle sympathetic nerve activity in response to hyperacute intermittent hypoxia versus placebo control.

Among the most promising pharmacological approaches studied to date are those based on N-acetylcysteine (NAC), Vitamin C, Leptin, Dronabinol, or Atomoxetine + Oxybutynin, but all require further experimentation. The human trial data for NAC is limited by its very small sample size (n=20) and short duration; evidence is currently characterized as preliminary.

Zinc

Scientific Evidence: Zinc is an essential trace element that may have sleep-promoting effects through its influence on neurotransmitter systems involved in sleep regulation, particularly melatonin. Evidence from RCTs suggests that zinc supplementation may improve sleep quality and reduce insomnia severity in individuals with sleep disturbances, such as shift-work disorder and age-related insomnia. Although generally well-tolerated at recommended doses, high doses of zinc can cause adverse effects. Further research is required to establish the optimal dose and formulation of zinc for sleep-related conditions.

Evidence connecting zinc specifically to OSA severity (rather than general sleep quality) remains weak and indirect.

Antioxidant Vitamins (C and E)

Scientific Evidence: Emerging research suggests that integrative interventions, such as antioxidants, can improve sleep quality and respiratory function in patients with sleep apnea. Given the well-established role of oxidative stress in OSA pathophysiology, antioxidant vitamins have mechanistic rationale, but large, well-controlled clinical trials specifically targeting OSA outcomes are lacking. Available data come primarily from small pilot studies.

5. Herbs and Botanical Ingredients

Valerian (Valeriana officinalis)

Traditional Use: Valerian root has been used medicinally since ancient Greece for its calming and sedating properties. Traditionally prepared as a tea, tincture, or dried root extract, it was used throughout European herbalism for insomnia, anxiety, and nervous exhaustion.

Scientific Evidence: Valerian's activity on sleep disturbances has been attributed to the presence of isovaleric acids and valepotriates with reported calming action and GABA reuptake inhibition with sedative effects. Despite controversial and conflicting data in the literature, several studies showed that valerian (160–600 mg/day) improved sleep quality and reduced sleep latency and duration; valerian also appears more effective for chronic insomnia than acute episodes.

Findings from a literature review suggest that certain supplements, particularly valerian, hops, and melatonin, could be effective in improving sleep quality and reducing insomnia symptoms through modulation of neurotransmitter systems and regulation of sleep-wake cycles. Evidence for valerian specifically modifying OSA pathophysiology (i.e., reducing AHI) is absent; its relevance to OSA is indirect, relating to general sleep quality improvement.

Hops (Humulus lupulus)

Traditional Use: Hops strobiles have a long history in European herbal medicine as a mild sedative and bitter tonic, traditionally used in combination preparations for nervous sleep disorders. In Germany, hops are covered under Commission E for nervous sleep disturbances.

Scientific Evidence: Hops has calming, sleep-inducing, gastric secretion-stimulating, and spasmolytic properties. Increasing GABAergic activity appears to be the main mechanism of action, with demonstrated binding affinities to melatonin and serotonin receptors. Its sedative characteristics have been confirmed in a clinical trial in association with valerian, where sleep latency and quality were improved. However, monotherapy studies showed no relevant effectiveness in sleep.

Chamomile (Matricaria chamomilla)

Traditional Use: Chamomile has been used since ancient times across European and Middle Eastern herbal traditions as a gentle sedative, anti-spasmodic, and anxiolytic, typically consumed as a tea before sleep.

Scientific Evidence: Chamomile, renowned for its gentle sedative properties, contains apigenin, an antioxidant that binds to specific receptors in the brain to induce drowsiness. Chamomile is often consumed in tea and is considered safe for most individuals. As with valerian, evidence for chamomile directly modifying OSA severity is absent; it is studied for general sleep quality and anxiety reduction.

Lavender (Lavandula angustifolia)

Traditional Use: Lavender has been used in European folk medicine as an aromatic anxiolytic and sleep aid, typically administered via inhalation (aromatherapy) or topical application.

Scientific Evidence: There is promising evidence of lavender efficacy for sleep disorders in a wide variety of populations and diseases; it was mentioned to be as effective as lorazepam in adults with anxiety and sleeping problems. With a dose of 80 mg, a reduction in sleep awakenings and improvements in sleep duration and overall sleep quality and anxiety were observed. Evidence linking lavender specifically to OSA is absent; its studied effects are on general sleep quality and anxiety.

Kampo Formula: Hange-koboku-to (Ban Xia Hou Po Tang)

Traditional Use: In traditional Japanese (Kampo) and Chinese medicine, this classical formula — comprising Pinellia, Hoelen (Poria), Magnolia bark, Perilla, and ginger — is used for conditions involving qi stagnation with phlegm, presenting as a sensation of obstruction in the throat, cough, and respiratory discomfort.

Scientific Evidence: In 2002, Japanese researchers reported on the case of a 44-year-old male who was successfully treated for obstructive sleep apnea by taking a Kampo extract. This formula consists of five medicinal herbs: Pinellia, Hoelen, Magnolia bark, Perilla, and ginger. The extract was administered at 5.0 g/day at bedtime. Sleep apnea started to improve after 10 days, and after 7 months there were no adverse effects. This is a single case report; evidence is anecdotal and insufficient to support clinical recommendations.

Melatonin

Traditional / Historical Use: Not a plant traditionally used in folk medicine; melatonin is an endogenous hormone that has been studied extensively as a supplement to regulate circadian rhythm and improve sleep onset since the late 20th century.

Scientific Evidence: Evidence suggests melatonin could be effective in improving sleep quality and reducing insomnia symptoms through regulation of sleep-wake cycles. Some researchers have noted that OSA can disrupt circadian rhythms and suppress endogenous melatonin secretion, providing a theoretical basis for supplementation, but evidence that melatonin reduces OSA severity (measured by AHI) is currently preliminary and mixed.

6. Dietary Patterns and Lifestyle Factors

Mediterranean Dietary Pattern

Among modifiable risk factors, diet quality has been suggested to influence sleep features. The Mediterranean diet is considered a landmark dietary pattern in terms of quality and effects on human health. The main features characterizing this dietary pattern include a prevalence of plant-derived foods such as vegetables, fruit, and whole grains as main sources of energy, vitamins, phytochemicals, and fiber; nuts and legumes as sources of healthy fats and proteins; moderate intake of animal-derived foods; occasional consumption of sweets; extra-virgin olive oil as dressing; and moderate consumption of wine providing phytochemicals such as polyphenols.

The "MIMOSA" randomized clinical trial examined the effectiveness of a weight-loss Mediterranean diet/lifestyle intervention in the management of obstructive sleep apnea (published in Clinical Nutrition, 2021). The study examined whether a weight-loss Mediterranean dietary/lifestyle intervention alongside usual CPAP treatment could improve OSA severity as well as other OSA-related outcomes more than standard care alone.

A systematic review comprised 23 reports describing the relation between adherence to the Mediterranean diet and different sleep features, including sleep quality, sleep duration, daytime sleepiness, and insomnia symptoms. Despite a large body of evidence on the linkage between dietary intakes and sleep patterns, findings are controversial.

Weight Loss Through Dietary Intervention

Obesity predisposes to OSA, and the prevalence of OSA is increasing worldwide because of the ongoing epidemic of obesity. Weight loss via caloric restriction is among the most consistently supported lifestyle interventions for reducing OSA severity, particularly in overweight and obese individuals. Approximately a 10% increase in weight, especially in males, might alert clinicians to consider potential or worsening OSA. By extension, reductions in body weight — particularly central adiposity — are mechanistically expected to reduce airway loading and improve OSA severity.

Anti-Inflammatory and Antioxidant Dietary Components

OSA-associated inflammation is thought to arise from two major sources. For one, mechanical damage due to snoring, breathing effort, and upper airway obstruction is associated with elevated immune cells in nasal and oropharyngeal mucosa, breath condensate, and sputum. OSA patients experience a unique pattern of oxygen deficiency — termed intermittent hypoxia (IH) — in which short, repetitive cycles of oxygen desaturation are followed by rapid reoxygenation of tissue. These mechanisms provide rationale for dietary strategies emphasizing antioxidant-rich foods.

Alcohol Avoidance

Alcohol, a central nervous system depressant with peripheral muscle relaxant effects, could theoretically exert an important moderating effect on the incidence and severity of OSA. A systematic meta-analysis quantified this effect: on average, alcohol consumption increased the apnea-hypopnea index (AHI) by about 4 events per hour and reduced minimum oxygen saturation by approximately 2–3%, compared to a control night without alcohol. Reduction or elimination of alcohol intake — particularly in the hours before sleep — is supported by systematic review-level evidence.

Physical Activity and Exercise

The mean number of steps per day among OSA patients across studies was 5,388 (95% CI: 3,831–6,945), which was by far lower than the recommended threshold of 10,000 steps per day. There was a significant decrease in apnea-hypopnea-index following exercise training (mean decrease of 8.9 events/h; 95% CI: −13.4 to −4.3), which was accompanied by a reduction in subjective sleepiness, an increase in VO₂ peak, and no change in BMI. OSA patients present low levels of physical activity, and exercise training is associated with improved outcomes. This meta-analysis finding is notable because the AHI reduction occurred independently of BMI change, suggesting exercise exerts direct physiological effects beyond weight loss alone.

Sleep Position

Supine (back) sleeping position promotes greater upper airway collapse in many OSA patients. Positional therapy — interventions designed to prevent supine sleeping — has been investigated as an adjunct strategy. One study reported that only 41.6% of patients maintained regular use of positional therapy devices at six months, with higher adherence and more favorable therapeutic outcomes observed in individuals with mild-to-moderate OSA compared to those with severe disease.

References

• Yayan J, Rasche K. Sleep apnea pathophysiology. Sleep and Breathing, 2023. PMC10656321
• White DP. Pathophysiology of Sleep Apnea. Physiological Reviews, 2009. American Physiological Society
• News-Medical: Obstructive Sleep Apnea Pathophysiology
• Journal of Oral Medicine and Pain: Obstructive Sleep Apnea — Pathophysiology and Treatment, 2024
• Eckert DJ, Malhotra A. Pathophysiology of Adult Obstructive Sleep Apnea. Proc Am Thorac Soc, 2008. PMC2628457
• Yayan J, Rasche K. A Systematic Review of Risk Factors for Sleep Apnea. Prev Med Rep, 2024. PMC11089396
• Slowik JM et al. Association and Risk Factors for Obstructive Sleep Apnea and Cardiovascular Diseases: A Systematic Review. PMC8700568
• Sauvet F et al. Longitudinal risk factors for obstructive sleep apnea: A systematic review. Sleep Medicine Reviews, 2023
• Yao M et al. Exploring the link between vitamin D deficiency and obstructive sleep apnea: A comprehensive review. J Sleep Res, 2024. PubMed 38414320
• Gupta R et al. Vitamin D deficiency: A forgotten aspect in sleep disorders? A critical update. Sleep Medicine, 2024
• Mete T et al. Obstructive sleep apnea and objective short sleep duration are independently associated with the risk of serum vitamin D deficiency. PMC5501615
• Drager LF et al. Obstructive Sleep Apnea: A Cardiometabolic Risk in Obesity and the Metabolic Syndrome. PMC4461232
• Sawada A et al. The Impact of Intermittent Hypoxia on Metabolism and Cognition. PMC9654766
• Romero-Corral A et al. Metabolic dysfunction in obstructive sleep apnea: A critical examination of underlying mechanisms. PMC4583137
• Maniaci A et al. Molecular Pathology, Oxidative Stress, and Biomarkers in Obstructive Sleep Apnea. PMC10058074
• Mateika JH et al. N-Acetyl Cysteine Reduces Hyper-Acute Intermittent Hypoxia Induced Sympathoexcitation in Human Subjects. PMC4817372
• Díaz-Jara E et al. Chronic Intermittent Hypoxia-Induced Vascular Dysfunction in Rats is Reverted by N-Acetylcysteine Supplementation and Arginase Inhibition. PMC6066978
• Godos J et al. Mediterranean Diet and Sleep Features: A Systematic Review of Current Evidence. PMC10821402
• Fallah M et al. Mediterranean diet adherence and sleep pattern: a systematic review of observational studies. PMC10913350
• Dobrosielski DA et al. Effect of the Implementation of a Structured Diet Management Plan on the Severity of Obstructive Sleep Apnea: A Systematic Review. Curr Nutr Rep, 2022
• Kolla BP et al. The Impact of Alcohol on Breathing Parameters during Sleep: A Systematic Review and Meta-analysis. PMC8520474
• Mendelson M et al. Obstructive Sleep Apnea Syndrome, Objectively Measured Physical Activity and Exercise Training Interventions: A Systematic Review and Meta-Analysis. PMC5827163
• Guadagna S et al. Herbal and Natural Supplements for Improving Sleep: A Literature Review. PMC11321869
• Ferracioli-Oda E et al. A systematic review of effectiveness and safety of some herbal compounds as treatment for primary insomnia. PMC11859059
• Draganova A et al. Investigating the Relationship between Obstructive Sleep Apnoea, Inflammation and Cardio-Metabolic Diseases. PMC10095553
• Positional Therapy: A Real Opportunity in the Treatment of Obstructive Sleep Apnea? An Update from the Literature. Life (MDPI), 2025
• Bonsignore MR et al. Obstructive Sleep Apnea and the Metabolic Syndrome: The Road to Clinically-Meaningful Phenotyping. PMC6221996